Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: A phase I/IIa double-blind, randomized controlled trial

Circulation

Volumn 115, Issue 25, 2007, Pages 3165-3172

  Losordo, Douglas W ^a,b,i   Schatz, Richard A ^c   White, Christopher J ^d   Udelson, James E ^e   Veereshwarayya, Vimal ^a,b   Durgin, Michelle ^a,b   Poh, Kian Keong ^b   Weinstein, Robert ^b   Kearney, Marianne ^b   Chaudhry, Muqtada ^b   Burg, Aaron ^b   Eaton, Liz ^b   Heyd, Lindsay ^b   Thorne, Tina ^a,b   Shturman, Leon ^b   Hoffmeister, Peter ^b   Story, Ken ^f   Zak, Victor ^b   Dowling, Douglas ^h   Traverse, Jay H ^g   Olson, Rachel E ^g   Flanagan, Janice ^b   Sodano, Donata ^b   Murayama, Toshinori ^b   Kawamoto, Atsuhiko ^b   Kusano, Kengo Fukushima ^b   Wollins, Jill ^b   Welt, Frederick ^b   Shah, Pinak ^b   Soukas, Peter ^b   Asahara, Takayuki ^b   Henry, Timothy D ^g   more..

^a NORTHWESTERN UNIVERSITY   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

^c SCRIPPS GREEN HOSPITAL   (United States)

^d OCHSNER CLINIC FOUNDATION   (United States)

^e TUFTS MEDICAL CENTER   (United States)

^f BAXTER HEALTHCARE CORPORATION   (United States)

^g MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^h Cardiovascular Core Laboratories Inc   (United States)

ⁱ NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

Angina; Angiogenesis; Endothelium; Ischemia; Stem cells

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; PLACEBO;

ADULT; AGE DISTRIBUTION; AGED; ANEMIA; ANGINA PECTORIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLEEDING; CARDIOVERSION; CD34+ T LYMPHOCYTE; CEREBROVASCULAR ACCIDENT; CLAUDICATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAM; ELECTROLYTE DISTURBANCE; ENDOCRINE DISEASE; FEMALE; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL SYMPTOM; HEART ATRIUM ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; KIDNEY FAILURE; LEUKAPHERESIS; LOW DRUG DOSE; MALE; PERICARDIAL EFFUSION; PERIPHERAL VASCULAR DISEASE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY ARREST; SEX RATIO; SUDDEN DEATH; T LYMPHOCYTE; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGINA PECTORIS; CARDIOVASCULAR AGENTS; CELL COUNT; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY, AMBULATORY; EXERCISE TOLERANCE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INJECTIONS; MALE; MIDDLE AGED; MYOCARDIUM; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; QUALITY OF LIFE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 34347402502     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.687376     Document Type: Article

References (28)

1. Yang EH, Barsness GW, Gersh BJ, Chandrasekaran K, Lerman A. Current and future treatment strategies for refractory angina. Mayo Clin Proc. 2004;79:1284-1292.
2. Mukherjee D, Bhatt DL, Roe MT, Patel V, Ellis SG. Direct myocardial revascularization and angiogenesis: how many patients might be eligible? Am J Cardiol. 1999;84:598-600.
3. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 2001;7:430-436.
4. Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, Milliken C, Uchida S, Masuo O, Iwaguro H, Ma H, Hanley A, Silver M, Kearney M, Losordo DW, Isner JM, Asahara T. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation. 2003;107:461-468.
5. Iwasaki H, Kawamoto A, Ishikawa M, Oyamada A, Nakamori S, Nishimura H, Sadamoto K, Horii M, Matsumoto T, Murasawa S, Shibata T, Suehiro S, Asahara T. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation. 2006;113:1311-1325.
6. Kawamoto A, Iwasaki H, Kusano K, Murayama T, Oyamada A, Silver M, Hulbert C, Gavin M, Hanley A, Ma H, Kearney M, Zak V, Asahara T, Losordo DW. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation. 2006;114:2163-2169.
7. Fukumoto Y, Miyamoto T, Okamura T, Gondo H, Iwasaki H, Horiuchi T, Yoshizawa S, Inaba S, Harada M, Niho Y. Angina pectoris occurring during granulocyte colony-stimulating factor-combined preparatory regimen for autologous peripheral blood stem cell transplantation in a patient with acute myelogenous leukaemia. Br J Haematol. 1997;97:666-668.
8. Vale PR, Losordo DW, Milliken CE, Maysky M, Esakof DD, Symes JF, Isner JM. Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation. 2000;102:965-974.
9. Wilson RF, Henry TD. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: double-edged swords. J Am Coll Cardiol. 2005;46:1649-1650.
10. Sinha S, Poh KK, Sodano D, Flanagan J, Ouilette C, Kearney M, Heyd L, Wollins J, Losordo D, Weinstein R. Safety and efficacy of peripheral blood progenitor cell mobilization and collection in patients with advanced coronary heart disease. J Clin Apher. 2006;21:116-120.
11. Rasmussen MM, Reimer KA, Kloner RA, Jennings RB. Infarct size reduction by propranolol before and after coronary ligation in dogs. Circulation. 1977;56:794-798.
12. Kloner RA, Ellis SG, Lange R, Braunwald E. Studies of experimental coronary artery reperfusion: effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage. Circulation. 1983;68(pt 2):I-8-I-15.
13. Ambrosio G, Weisman HF, Mannisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation. 1989;80:1846-1861.
14. Agata J, Chao L, Chao J. Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction. Hypertension. 2002;40:653-659.
15. Lund GK, Watzinger N, Saeed M, Reddy GP, Yang M, Araoz PA, Curatola D, Bedigian M, Higgins CB. Chronic heart failure: global left ventricular perfusion and coronary flow reserve with velocity-encoded cine MR imaging: initial results. Radiology. 2003;227:209-215.
16. Selvanayagam JB, Jerosch-Herold M, Porto I, Sheridan D, Cheng AS, Petersen SE, Searle N, Channon KM, Banning AP, Neubauer S. Resting myocardial blood flow is impaired in hibernating myocardium: a magnetic resonance study of quantitative perfusion assessment. Circulation. 2005;112:3289-3296.
17. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation. 2004;109:2692-2697.
18. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:E1-E7.
19. Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, Martin H, Zeiher AM, Dimmeler S. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation. 2004;109:1615-1622.
20. Murasawa S, Llevadot J, Silver M, Isner JM, Losordo DW, Asahara T. Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation. 2002;106:1133-1139.
21. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-967.
22. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, Silver M, Ma H, Kearney M, Isner JM, Asahara T. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation. 2001;103:634-637.
23. Assmus B, Honold J, Schachinger V, Britten MB, Fischer-Rasokat U, Lehmann R, Teupe C, Pistorius K, Martin H, Abolmaali ND, Tonn T, Dimmeler S, Zeiher AM. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med. 2006;355:1222-1232.
24. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Suselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355:1210-1221.
25. Kawamoto A, Murayama T, Kusano K, Ii M, Tkebuchava T, Shintani S, Iwakura A, Johnson I, von Samson P, Hanley A, Gavin M, Curry C, Silver M, Ma H, Kearney M, Losordo DW. Synergistic effect of bone marrow mobilization and vascular endothelial growth factor-2 gene therapy in myocardial ischemia. Circulation. 2004;110:1398-1405.
26. Rana JS, Mannam A, Donnell-Fink L, Gervino EV, Sellke FW, Laham RJ. Longevity of the placebo effect in the therapeutic angiogenesis and laser myocardial revascularization trials in patients with coronary heart disease. Am J Cardiol. 2005;95:1456-1459.
27. Parisi AF, Folland ED, Hartigan P; Veterans Affairs ACME Investigators. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med. 1992;326:10-16.
28. Red-Horse K, Ferrara N. Imaging tumor angiogenesis. J Clin Invest. 2006;116:2585-2587.